Estimation of the risk of metastatic relapse is a major challenge to decide treatment options for early-stage breast cancer patients. To date, metastasis free survival (MFS) analysis mainly relies on classical - agnostic - statistical models (e.g., Cox regression). Instead, we propose to derive mechanistic models to predict MFS.The data...
-
April 8, 2022 (v1)Conference paperUploaded on: April 5, 2025
-
July 2022 (v1)Publication
No description
Uploaded on: April 5, 2025 -
April 2023 (v1)Journal article
Estimating the risk of metastatic relapse is a major challenge to decide adjuvant treatment options in early-stage breast cancer (eBC). To date, distant metastasis-free survival (DMFS) analysis mainly relies on classical, agnostic, statistical models (e.g., Cox regression). Instead, we propose here to derive mechanistic models of DMFS.
Uploaded on: April 5, 2025